Literature DB >> 30468998

Initial cell maturity changes following transplantation in a hyaluronan-based hydrogel and impacts therapeutic success in the stroke-injured rodent brain.

Samantha L Payne1, Anup Tuladhar2, Jaclyn M Obermeyer1, Balazs V Varga3, Carter J Teal2, Cindi M Morshead4, Andras Nagy5, Molly S Shoichet6.   

Abstract

Ischemic stroke results in a loss of neurons for which there are no available clinical strategies to stimulate regeneration. While preclinical studies have demonstrated that functional recovery can be obtained by transplanting an exogenous source of neural progenitors into the brain, it remains unknown at which stage of neuronal maturity cells will provide the most benefit. We investigated the role of neuronal maturity on cell survival, differentiation, and long-term sensorimotor recovery in stroke-injured rats using a population of human cortically-specified neuroepithelial progenitor cells (cNEPs) delivered in a biocompatible, bioresorbable hyaluronan/methylcellulose hydrogel. We demonstrate that transplantation of immature cNEPs result in the greatest tissue and functional repair, relative to transplantation of more mature neurons. The transplantation process itself resulted in the least cell death and phenotypic changes in the immature cNEPs, and the greatest acute cell death in the mature cells. The latter negatively impacted host tissue and negated any potential positive effects associated with cell maturity and the hydrogel vehicle, which itself showed some functional and tissue benefit. Moreover, we show that more mature cell populations are drastically altered during the transplantation process itself. The phenotype of the cells before and after transplantation had an enormous impact on their survival and the consequent tissue and behavioral response, emphasizing the importance of characterizing injected cells in transplantation studies more broadly.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Cell differentiation; Cell transplantation; Cerebral cortex; Neurons; Regeneration; Stem cells

Mesh:

Substances:

Year:  2018        PMID: 30468998     DOI: 10.1016/j.biomaterials.2018.11.020

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  5 in total

Review 1.  Injectable biomaterial shuttles for cell therapy in stroke.

Authors:  Juhi Samal; Tatiana Segura
Journal:  Brain Res Bull       Date:  2021-08-12       Impact factor: 3.715

Review 2.  Applying hiPSCs and Biomaterials Towards an Understanding and Treatment of Traumatic Brain Injury.

Authors:  María Lacalle-Aurioles; Camille Cassel de Camps; Cornelia E Zorca; Lenore K Beitel; Thomas M Durcan
Journal:  Front Cell Neurosci       Date:  2020-11-12       Impact factor: 5.505

3.  An Injectable Hyaluronan-Methylcellulose (HAMC) Hydrogel Combined with Wharton's Jelly-Derived Mesenchymal Stromal Cells (WJ-MSCs) Promotes Degenerative Disc Repair.

Authors:  Un Yong Choi; Hari Prasad Joshi; Samantha Payne; Kyoung Tae Kim; Jae Won Kyung; Hyemin Choi; Michael J Cooke; Su Yeon Kwon; Eun Ji Roh; Seil Sohn; Molly S Shoichet; Inbo Han
Journal:  Int J Mol Sci       Date:  2020-10-07       Impact factor: 5.923

4.  Quo vadis? Bioengineered polysaccharide-based hydrogel scaffolds for damaged central nervous system recovery and regeneration.

Authors:  Isadora C Carvalho; Herman S Mansur
Journal:  Neural Regen Res       Date:  2022-07       Impact factor: 5.135

5.  The Potential of Biomaterial-Based Approaches as Therapies for Ischemic Stroke: A Systematic Review and Meta-Analysis of Pre-clinical Studies.

Authors:  Faye Bolan; Irene Louca; Calvin Heal; Catriona J Cunningham
Journal:  Front Neurol       Date:  2019-08-27       Impact factor: 4.086

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.